Wedbush started coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) in a research note released on Friday morning, Marketbeat reports. The firm issued an outperform rating and a ...
Insulet (NASDAQ:PODD – Get Free Report) had its target price upped by equities researchers at Wells Fargo & Company from $305 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback